Mitchell Mcleod Pugh & Williams Inc Amarin Corp Plcuk Transaction History

Mitchell Mcleod Pugh & Williams Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$1.13 - $3.69 $12,723 - $41,549	-11,260 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$3.24 - $5.18 $18,529 - $29,624	-5,719 Reduced 33.68%	11,260 $38,000
Q2 2020 Jul 17, 2020	BUY	$4.78 - $8.26 $27,336 - $47,238	5,719 Added 50.79%	16,979 $117,000
Q1 2020 Apr 08, 2020	BUY	$4.0 - $21.53 $45,040 - $242,427	11,260 New	11,260 $45,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.